Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03831477 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles
A NA study of Wrinkle and Rhytides, sponsored by Venus Concept.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT03831477: Completed NA study of Wrinkle and Rhytides, sponsored by Venus Concept.
NCT03831477 is a NA study of Wrinkle and Rhytides that has completed, run by Venus Concept. The registered enrollment target is 15 participants, below the 120-participant average among 25 other Wrinkle trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03831477, a NA study of Wrinkle and Rhytides, has completed, sponsored by Venus Concept.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of facial wrinkles.
Primary Outcome
Change in facial wrinkles at 12 weeks post-treatment compared to baseline as assessed by blinded evaluators by photographic assessment utilizing the 9-point Fitzpatrick Wrinkle and Elastosis Scale (FWES). Scores of 1-3 indicate fine wrinkles with mild elastosis, scores 4-6 fine to moderate depth wrinkles with moderate elastosis and 7-9 fine to deep wrinkles with severe elastosis.
Interventions
- DEVICE Venus Viva
Study Locations (1)
New York
- Sadick Research Group - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-12-12 |
| Est. Completion | 2019-08-09 |
| Phase | NA |
What the finished NCT03831477 record still lists
NCT03831477 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 120-participant average among 25 other Wrinkle trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which Venus Viva is the first listed.
NCT03831477 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03831477 about?
NCT03831477 is a clinical study titled "Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles". Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of facial wrinkles.
What is the current status of trial NCT03831477?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-12-12. Estimated completion is 2019-08-09.
What conditions does trial NCT03831477 study?
This clinical trial studies the following conditions: Wrinkle, Rhytides.
What interventions are being tested in trial NCT03831477?
The interventions under investigation include: Venus Viva (DEVICE).
Who is sponsoring clinical trial NCT03831477?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03831477 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03831477's enrollment target sits among peer trials
15 23rd of 25 higher than 3 of 25 other Wrinkle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wrinkle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI